A group of researchers from Japan has presented the results of their work concerning the delayed side effects of mRNA vaccines against COVID-19, developed by Pfizer and Moderna (which were not used in Russia). According to their data, after the administration of such vaccines, components containing mRNA encoding the virus’s S-protein, as well as the lipid nanoparticles themselves, can remain in the human body for several years. These residual substances, scientists claim, possess potential toxicity and may contribute to the development of serious conditions such as thrombosis and inflammatory reactions. Of particular concern is the possibility of transmitting these components through donor blood, as well as during organ and bone marrow transplantation. The authors of the study call for a review of current COVID-19 vaccination practices, emphasizing the need for deeper study and control of the risks associated with this technology. These concerns echo previously expressed opinions about the insufficient study of mRNA preparations, especially when used in healthy individuals, and studies that have already emerged regarding complications such as heart muscle damage.
About the Author
